Skip to Content
scroll

Australian Clinical Labs Ltd (ACL)

ASX.ACL $2.62

20 MINUTE DELAYED

14 DAYS FREE ACCESS

Join Market Matters and get full access
to all our Opinion + Action

LEARN MORE

ASX.ACL $2.62

20 MINUTE DELAYED

TODAY

0.00 %

1 YEAR RETURN

0.00%

VOLUME

0

DIV YIELD

0%

PE RATIO

14.64

52 WEEK RANGE

2.47

3.87

ANALYSIS

i

SHARE PRICE ACTIVITY
Last (Price)

2.62

Change

0.00 (0.00)

Bid / Ask

2.54 - 2.62

Volume

0

Volume (3mths avg)

0

Turnover

0

Open

0.00

Day Range

2.55 - 2.62

VWAP

0.00

Prev Close

2.62

Last Trade

01/12 6:10am (AEST)

i

KEY INFORMATION
Sector

Healthcare

Shares Issued

114,242,806

NTA/Share

0.00

Last Dividend

0.07

Dividend Ex Date

14 SEP 2023

Dividend Pay Date

03 OCT 2023

i

BROKER CALLS

current

Mean

2.00

Target Price

0.00

BUY

i

CURRENT ()
Revenue

995.60

EBITDA

380.10

Profit

184.50

Earnings Per Share (EPS)

0

Dividend Per Share (DPS)

0

Yield %

0.00

Market Cap

0

Price to Earnings Ratio (P/E)

14.64

i

TARGET PRICE FORECAST

i

ESTIMATES ()
Revenue

690.42

EBITDA

191.17

Profit

36.81

Earnings Per Share (EPS)

0.18

Dividend Per Share (DPS)

0.12

i

BROKER CONSENSUS RECOMMENDATION

BUY

SELL

Target Price

0.00

Lt Growth Rate

0.00

Recommendation (BUY)

2.00
OPINION
image description

Business Summary

Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients, and corporate clients, including routine pathology tests, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology and cytopathology, hematology, allergy and immunology, serology and microbiology, infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.

image description

Relevant suggested news and content from the site

image description

Only available to Members

Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing. Click here
Back to top